Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
5.62
+0.12 (2.18%)
At close: Aug 13, 2025, 4:00 PM
5.60
-0.02 (-0.36%)
After-hours: Aug 13, 2025, 6:52 PM EDT
Bolt Biotherapeutics Market Cap
Bolt Biotherapeutics has a market cap or net worth of $10.77 million as of August 13, 2025. Its market cap has decreased by -61.82% in one year.
Market Cap
10.77M
Enterprise Value
-3.36M
1-Year Change
-61.82%
Ranking
Category
Stock Price
$5.62
Market Cap Chart
Since the IPO on February 5, 2021, Bolt Biotherapeutics's market cap has decreased from $690.43M to $10.77M, a decrease of -98.44%. That is a compound annual growth rate of -60.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 10.77M | -47.39% |
| Dec 31, 2024 | 20.48M | -51.84% |
| Dec 29, 2023 | 42.52M | -13.15% |
| Dec 30, 2022 | 48.96M | -73.20% |
| Dec 31, 2021 | 182.69M | -73.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 419.89B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |